| Not Yet Recruiting | Oral N-acetylglucosamine in Crohn's Disease NCT07225998 | Johns Hopkins University | Phase 2 |
| Not Yet Recruiting | Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy NCT07089771 | Region Stockholm | N/A |
| Recruiting | Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Entero NCT07431983 | Asian Institute of Gastroenterology, India | — |
| Not Yet Recruiting | OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity NCT07240181 | Andreas Munk Petersen | — |
| Recruiting | Magnesium in Gastrointestinal Disease NCT07338565 | University of Aarhus | — |
| Not Yet Recruiting | Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD NCT07169123 | McMaster University | — |
| Not Yet Recruiting | Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease an NCT07059130 | Rubix LS | Phase 4 |
| Recruiting | Treatment of Moderate to Severe Refractory Crohn's Disease NCT06721962 | Tr1X, Inc. | Phase 1 / Phase 2 |
| Recruiting | A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Cr NCT06890637 | All India Institute of Medical Sciences | N/A |
| Recruiting | A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants NCT06663332 | Janssen Research & Development, LLC | Phase 3 |
| Recruiting | Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participan NCT06670638 | Alimentiv Inc. | — |
| Recruiting | Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS) NCT06723418 | University of Glasgow | — |
| Recruiting | Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflam NCT06001450 | Icahn School of Medicine at Mount Sinai | — |
| Active Not Recruiting | Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease NCT05910528 | Hoffmann-La Roche | Phase 2 |
| Completed | AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to NCT05452304 | AstraZeneca | Phase 1 |
| Completed | A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) NCT04885920 | Takeda | — |
| Completed | A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgi NCT04959851 | Takeda | — |
| Completed | A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Pra NCT04989907 | Takeda | — |
| Completed | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice NCT04890262 | Takeda | — |
| Active Not Recruiting | A Study of Surgical Interventions in Fistulizing Conditions NCT04940611 | Takeda | — |
| Withdrawn | Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease NCT04151225 | GlaxoSmithKline | Phase 2 |
| Completed | A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease NCT04397263 | Janssen Pharmaceutical K.K. | Phase 3 |
| Completed | Perianal Fistula (PAF) Validation and Burden of Illness Study NCT03981939 | Takeda | — |
| Terminated | Maintenance Dosing of Vitamin D in Crohn's Disease NCT03615378 | Cedars-Sinai Medical Center | EARLY_Phase 1 |
| Unknown | Integrative Gastroenterology - an Observational Trial NCT02476643 | Universität Duisburg-Essen | — |
| Completed | Extensive Mesenteric Excision (EME) Versus Local Mesenteric Excision (LME) for Crohn's Disease NCT02542904 | Jinling Hospital, China | N/A |
| Completed | Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort NCT02503514 | University of North Carolina, Chapel Hill | — |
| Completed | Pneumococcal Vaccination of Crohn Patients NCT01947010 | Statens Serum Institut | Phase 4 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of I NCT01769755 | Celularity Incorporated | Phase 1 |
| Terminated | EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment NCT01582568 | Baylor College of Medicine | — |
| Completed | Comparative Effectiveness of MR Enterography NCT01593462 | University of Michigan | N/A |
| Unknown | IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. NCT02130349 | Maastricht University Medical Center | — |
| Completed | Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas NCT01145365 | Vanderbilt University Medical Center | N/A |
| Terminated | Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease NCT01203254 | Florian Beigel | Phase 4 |
| Terminated | Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children NCT00946361 | Nationwide Children's Hospital | — |
| Completed | Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease NCT00774982 | Teva GTC | Phase 1 |
| Unknown | A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Dis NCT00731172 | Tel-Aviv Sourasky Medical Center | Phase 2 |
| Completed | Atorvastatin in Moderate Active Crohns Disease NCT00454545 | Skane University Hospital | Phase 2 |
| Unknown | Vitamin D Treatment for Crohn´s Disease NCT00132184 | University of Aarhus | Phase 2 / Phase 3 |
| Completed | Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases NCT00940576 | University of Jena | N/A |